Fundamental Flaws in Pfizer’s COVID-19 Biologics License Application Submission, and the Implications to the Safety and Effectiveness of These Novel Gene Therapy Vaccines
Philip R. Oldfield and Maria L. Gutschi The mRNA COVID-19 vaccines are using gene therapy technology in which the active product, the encoded spike protein, is not actually part of the formulation. Health Canada has used an inappropriate guidance document for the regulatory review, contrary to Good Scientific Practice, effectively compromising the safety of Canadians. […]
A New Pre-print Answers Some Questions About Age-related Immunopathologies Associated with empty LNPs
Jessica Rose A new preprint was uploaded on November 7, 2022 entitled: “Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals” by a ‘non-conflicted group of researchers’ from… Acuitas? Wait, what? … Acuitas is the Canadian Biotech company that makes the proprietary Pfizer/BioNTech LNPs. … the paper reveals […]
If We Don’t Know What’s in Covid Vaccines, How Can We Know What They’re Doing?
Rhoda Wilson Some researchers are finding graphene while others are not. There are many reports of degraded, low-purity mRNA while other researchers find there is none. Because vaccine manufacturers’ contracts prohibit independent analysis of their “vaccines” it’s difficult to legally obtain enough samples, from a broad spectrum of batches and locations, to establish what is […]
An Independent Analysis of the Manufacturing and Quality Issues of the BNT162b BioNTech/Pfizer Quasi-vaccine Based on the European Medicines Agency’s Public Assessment Report (EPAR)
L. Maria Gutschi et al. This article summarizes the main findings of a more detailed technical assessment concerning the development and manufacturing of the BioNTech/Pfizer’s COVID-19 quasi-vaccine BNT162b. A number of deficiencies in the product’s development were identified by regulatory agencies and appear to have either been ignored or glossed over. Vaccine approval for the […]
Pre-exposure to mRNA-LNP Inhibits Adaptive Immune Responses and Alters Innate Immune Fitness in an Inheritable Fashion
Zhen Qin et al. Hundreds of millions of SARS-CoV-2 mRNA-LNP vaccine doses have already been administered to humans. However, we lack a comprehensive understanding of the immune effects of this platform. The mRNA-LNP-based SARS-CoV-2 vaccine is highly inflammatory, and its synthetic ionizable lipid component responsible for the induction of inflammation has a long in vivo […]
Combining COVID-19 BA4/5 and Influenza mRNA
Peter A. McCullough Recently, both Pfizer and Moderna announced they were developing a combination injection utilizing mRNA coding for the BA4/BA5 Omicron subvariant and new mRNA coding for antigens contained in the influenza virus. Because the COVID-19 component is under Emergency Use Authorization plus questionable unorthodox licensure meant to provide the legal basis for a […]
That mRNA “Vaccines” Cause Cells to Produce Spike Proteins Is a Fairy Tale
Stefano Scoglio and Torsten Engelbrecht This is scientifically evident already from the fact that it’s impossible for mRNA to enter the cell and produce anything. Anybody who talks about spike proteins and embraces the story di fused by the pharmaceutical companies just accepts that as given. The researchers … indicate that these “vaccines” are so […]
The Surge in Childhood Infections: Are mRNA Vaccines the Solution – or the Cause?
Joseph Mercola Hospitals around the U.S. are suddenly struggling to keep up with surging rates of respiratory infections among children, such as respiratory syncytial virus (RSV), COVID-19, rhinoviruses and in uenza. Moderna is working on an mRNA jab for RSV, which is scheduled for release in 2023. They’re also working on a combination mRNA jab […]
